We are live on ! Find out more
AACR

ACR Alpine Capital Research Portfolio holdings

AUM $7.04B
1-Year Est. Return 28%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+28%
3 Year Est. Return
+58.09%
5 Year Est. Return
+55.24%
10 Year Est. Return
+208.51%
AUM
$1.85B
AUM Growth
+$688M
Cap. Flow
+$637M
Cap. Flow %
34.4%
Top 10 Hldgs %
80.84%
Holding
32
New
4
Increased
12
Reduced
9
Closed
2

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.57M
2
MSFT icon
Microsoft
MSFT
+$3.35M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.57M
4
INTC icon
Intel
INTC
+$1.48M
5
JPM icon
JPMorgan Chase
JPM
+$761K

Sector Composition

Rank Sector Weight
1 Industrials 14.88%
2 Communication Services 12.27%
3 Healthcare 11.79%
4 Technology 11.16%
5 Consumer Discretionary 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
26
MBIA
MBI
$267M
$449K 0.02%
51,600
CRK icon
27
Comstock Resources
CRK
$3.97B
$304K 0.02%
+50,000
New +$325K
VTI icon
28
Vanguard Morningstar Total Stock Market ETF
VTI
$669B
$162K 0.01%
1,247
AAPL icon
29
Apple
AAPL
$4.51T
-8,060
Closed -$290K
PG icon
30
Procter & Gamble
PG
$336B
-3,001
Closed -$262K

Similar funds

ACR Alpine Capital Research's Q3 2017 Portfolio in Review

As of Q3 2017, ACR Alpine Capital Research held 32 positions worth $1.85B, up 59% from $1.16B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

ACR Alpine Capital Research deployed $637M of net new capital in Q3 2017, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 5,291,121 shares worth $530M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 23% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $3.57M trimmed.

  • ACR Alpine Capital Research's largest Q3 2017 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 5,291,121 shares worth $530M.
  • ACR Alpine Capital Research added most to Vodafone in Q3 2017, an estimated $6.21M increase.
  • ACR Alpine Capital Research's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $3.57M.
  • ACR Alpine Capital Research fully exited Apple in Q3 2017, selling an estimated $290K.
  • ACR Alpine Capital Research's ten largest holdings make up 81% of its $1.85B portfolio in Q3 2017.
  • ACR Alpine Capital Research opened 4 new positions and closed 2 in Q3 2017.
  • ACR Alpine Capital Research's portfolio value rose 59% quarter-over-quarter to $1.85B.

Based on ACR Alpine Capital Research's 13F filing for Q3 2017, filed 7 Nov 2017.